SeaStar Medical Holding Corp (ICU)
0.3899
-0.01
(-3.01%)
USD |
NASDAQ |
May 17, 16:00
0.3765
-0.01
(-3.44%)
After-Hours: 20:00
SeaStar Medical Cash from Financing (Quarterly): 4.588M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.588M |
| September 30, 2023 | 1.397M |
| June 30, 2023 | 1.457M |
| March 31, 2023 | 2.972M |
| December 31, 2022 | 5.30M |
| Date | Value |
|---|---|
| September 30, 2022 | 0.35M |
| June 30, 2022 | 1.397M |
| March 31, 2022 | 0.284M |
| June 30, 2021 | 0.481M |
| March 31, 2021 | -0.001M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.001M
Minimum
Mar 2021
5.30M
Maximum
Dec 2022
1.822M
Average
1.397M
Median
Jun 2022
Cash from Financing (Quarterly) Benchmarks
| Nuwellis Inc | 0.50M |
| Ardelyx Inc | 52.97M |
| Adverum Biotechnologies Inc | 119.88M |
| Aquestive Therapeutics Inc | 81.74M |
| Vir Biotechnology Inc | -- |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.485M |
| Free Cash Flow | -10.28M |
| Free Cash Flow Per Share (Quarterly) | -0.0942 |
| Free Cash Flow Yield | -111.4% |